Comment from Kenvue Brands LLC part 4 of 4

AnonymousOtherOther
Summary: The submission consists of meeting minutes from two different FDA advisory committees (the Joint Pulmonary-Allergy Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee in 2015, and the Pediatric Advisory Committee in 2017) regarding the safety and use of codeine and hydrocodone in children. It does not express a specific stance on the "Americans for Scientific Integrity" citizen petition but rather provides historical regulatory context and committee findings.
Submission 4 of 4 in support of Kenvue Brands LLC’s response to the Citizen Petition

Attachments

View on Regulations.gov